Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II)

OBJECTIVE: This multicenter, single-arm phase II study (UMIN000008429) aimed to evaluate the efficacy and safety of capecitabine plus oxaliplatin (CapOX) as postoperative adjuvant chemotherapy for patients with locally advanced rectal cancer. METHODS: Patients with resectable clinical Stage II or II...

Descripción completa

Detalles Bibliográficos
Autores principales: Hattori, Norifumi, Nakayama, Goro, Uehara, Keisuke, Aiba, Toshisada, Ishigure, Kiyoshi, Sakamoto, Eiji, Tojima, Yuichiro, Kanda, Mitsuro, Kobayashi, Daisuke, Tanaka, Chie, Yamada, Suguru, Koike, Masahiko, Fujiwara, Michitaka, Nagino, Masato, Kodera, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946745/
https://www.ncbi.nlm.nih.gov/pubmed/31542847
http://dx.doi.org/10.1007/s10147-019-01546-3

Ejemplares similares

Ejemplares similares